Platinum Investment Management’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-20,000
Closed -$748K 97
2018
Q1
$748K Buy
+20,000
New +$841K 0.02% 76

Platinum Investment Management's ARMO Position: Q2 2018 in Review

Platinum Investment Management sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 20,000 shares — an estimated $748K sold.

Platinum Investment Management first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $748K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

  • Platinum Investment Management reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Platinum Investment Management sold 20,000 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $748K.
  • Platinum Investment Management first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Platinum Investment Management's ARMO BioSciences, Inc. Common Stock position peaked at $748K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Platinum Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.